Study Group: Revlimid Prescribers: Hematologists (US)

Council Members in this Study Group: 77

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

William Matsui

Associate Professor
Johns Hopkins University - CC
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

William Matsui, MD, is an Associate Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center and the Johns Hopkins School of Medicine in Maryland, since July 2008. Dr. Matsui specializes in clinical and laboratory examination of hematological...

5 news post(s)
Donald Fleming, Director of the Cancer Care Center , DAVIS HEALTH SYSTEM, INC.Donald Fleming

Director of the Cancer Care Center
DAVIS HEALTH SYSTEM, INC.
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Donald Fleming, MD, is presently the Director of the Cancer Care Center for the Davis Health System. He was the Head of Hematology-Oncology at the Medical Center of Vincennes until mid 2008. Previously, Dr. Fleming was a Tenured Professor in the Division...

116 news post(s)
Eric Jacobsen

Instructor in Medicine
DANA-FARBER CANCER INSTITUTE, INC.
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Eric Jacobsen, MD, is Medical Oncologist and Hematologist in the Hematology and Oncology Department at the Dana-Farber Cancer Institute in Boston, MA. Dr. Jacobsen is a member of the lymphoma and bone marrow transplant divisions at Dana-Farber Cancer...

Sujith Kalmadi

Staff Physician
Ironwood Cancer & Research Center
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Sujith Kalmadi, MD, is a Staff Physician at the Ironwood Cancer and Research Center in Phoenix, Arizona. Dr. Kalmadi has previously worked as a Clinical Assistant Professor at Baylor school of Medicine in Houston, Texas, and at the Lerner School of Medicine...

Alan List

Executive Vice President and Physician-in-Chief
MOFFITT CANCER CENTER
What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Alan List, MD, is Executive Vice President and Physician-in-Chief at the Moffitt Cancer Center in Tampa, FL and a Professor of Oncologic Sciences at the University of South Florida (USF). Dr. List is an expert on acute myeloid leukemia (AML) and myelodysplastic...

1 event(s)

View all Leading Experts in this Study Group

Join this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Physician - Division Head
  • Director
  • Partner
  • Owner

Related Study Groups

Study Group Name No. Members
Oncologists (US) 2218
Thalomid Prescribers for MDS (US) 44
Oncologists in Private Practice in the U.S. 463
Nexavar Prescribers: Oncologists 78
Colorectal Oncologists (US) 73
Surgeons who specialize in Transplantation 199
Ultram Prescribers (US) 57
Hematologists who Treat Lymphoma 104

GLG Live Meetings with this Study Group's Leading Experts (?)

December 11, 2007 | Atlanta

GLGi: Panel Review of the American Society of Hematology (ASH) 49th Annual Meeting

GLG Webcasts & Teleconferences

Leading Experts in Revlimid Prescribers: Hematologists (US) have not participated in any GLG webcasts.

View All GLG Webcasts & Teleconferences in Healthcare